St. Anna Childrens Cancer Research Institute
St. Anna Childrens Cancer Research Institute is recorded as a service provider in 4 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 4 of 4 trials · Latest update first
LBL 2018 – International cooperative treatment protocol for children and adolescents with lymphoblastic lymphoma
Sponsor Universitaetsklinikum Muenster AöR
- Start (EU)
- Latest update
- Estimated end
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 - A Randomized Phase III Study Conducted by the Resistant Disease Committee of the International BFM Study Group - IntReALL BCP 2020
Sponsor Charite Universitaetsmedizin Berlin KöR
- Start (EU)
- Not reported
- Latest update
- Estimated end
Glo-BNHL: A Global Study of Novel Agents in Paediatric and Adolescent Relapsed and Refractory B-cell Non-Hodgkin Lymphoma
Sponsor The University Of Birmingham
- Start (EU)
- Latest update
- Estimated end
AIEOP-BFM ALL 2017 - International collaborative treatment protocol for children and adolescents with acute lymphoblastic leukemia
Sponsor Universitaetsklinikum Schleswig-Holstein
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for St. Anna Childrens Cancer Research Institute?
The 2026-10-09 snapshot links St. Anna Childrens Cancer Research Institute to 4 distinct CTIS trials. Recorded services include Clinical monitoring, Co-sponsor for Austria, National Coordinating Center, National Coordinating Centre. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for St. Anna Childrens Cancer Research Institute?
The most frequently recorded therapeutic areas are Haematological Malignancies. Recorded phases include Phase 2, Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to St. Anna Childrens Cancer Research Institute conducted?
The linked trials record locations in 16 countries, including Austria, Czechia, Germany, Spain, Italy. These are trial locations, not confirmed office locations or countries where St. Anna Childrens Cancer Research Institute delivered services.
What can this page tell me about St. Anna Childrens Cancer Research Institute's trial experience?
Browse 4 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under St. Anna Childrens Cancer Research Institute. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- St. Anna Childrens Cancer Research Institute GmbH